Immunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.
In children, luteinizing hormone, along with follicle-stimulating hormone, is used to diagnose delayed and precocious (early) puberty. This assay is sensitive to 0.009 mIU/mL and is more appropriate for use in children. This assay offers a 10-fold increase in analytical sensitivity over existing automated immunoassays.
In children, follicle-stimulating hormone along with luteinizing hormone, is used to diagnose delayed and precocious (early) puberty. This assay is sensitive to 0.02 IU/L and is more appropriate for use in children. This assay offers a 10-fold increase in analytical sensitivity over existing automated immunoassays.
Dried blood spot specimen stability makes it a practical alternative to venous blood. Instead of traveling to a clinic to get blood drawn, a blood spot sample can be taken at a convenient site and mailed to a laboratory. It opens new possibilities in testing, such as comparison of historical to current patient results; simplified blood sampling for patients in remote locations, for those who are homebound or those that pre…
Wieslab Diagnostic Services offers a comprehensive range of individual markers and test panels and welcomes samples from customers worldwide. Wiselab's request forms list test panels and individual tests currently available in the areas of Autoimmunity, Neurology, and Monitoring of Biopharmaceuticals. We offer fast turnaround times and access to a medical specialist to discuss your results.
Closed, scalable electroporation system for GMP-compliant cell therapy manufacturing
Closed, scalable electroporation system for GMP-compliant cell therapy manufacturing
The LIAISON® SARS-CoV-2 TrimericS IgG assay enables the reliable detection of Trimeric S spike protein IgG antibodies – the body’s natural defense response against SARS-CoV-2.
The LumiraDx D-Dimer Test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify D-Dimer levels in whole blood and plasma. It is the only direct fingerstick D-Dimer assay available today*, aiding healthcare professionals to exclude deep vein thrombosis (DVT) and pulmonary embolism (PE) in symptomatic patients with confidence** - in only 6 minutes.
The LumiraDx HbA1c test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify HbA1c in fingerstick and venous whole blood. Used with the LumiraDx Platform, the LumiraDx HbA1c test delivers rapid, reliable results in approximately < 7 minutes at the point of care.
The LumiraDx NT-proBNP test is an easy to use, fast microfluidic immunoassay designed to rapidly quantify NT-proBNP in human capillary and venous whole blood and plasma samples (Lithium Heparin). Used with the LumiraDx Platform, the LumiraDx NT-proBNP test delivers rapid, reliable results in 12 minutes at the point of care.
The LumiraDx SARS-CoV-2 Ab Test is a microfluidic immunofluorescence assay for qualitative detection of total antibodies to SARS-CoV-2 in human whole blood (capillary fingerstick or venous), plasma or serum for indication of recent or prior infection. Used with the LumiraDx Platform the Test delivers rapid results at the point of care.
The LumiraDx SARS-CoV-2 Ag Test is a microfluidic immunofluorescence assay for the direct and qualitative detection of nucleocapsid protein antigen in nasal and nasopharyngeal swab specimens from individuals suspected of COVID-19 or asymptomatic individuals. Used with the LumiraDx Platform the test delivers rapid results at the point of care.
Lab-comparable results in just 5 minutes - With excellent performance and results in just 5 minutes, the LumiraDx SARS-CoV-2 Ag Ultra test enables you to accurately and confidently test more patients, optimize clinic workflows and help triage patients without delay
The LumiraDx SARS-CoV-2 Ag Pool Test is a rapid microfluidic immunofluorescence assay for the qualitative detection of the nucleocapsid protein antigen in nasal or nasopharyngeal swab specimens pooled from up to 5 individuals suspected of COVID-19 or up to 5 asymptomatic individuals. Used with the LumiraDx Platform the test offers a rapid, scalable and cost-effective screening solution for infectious individuals.
Enzyme Immunoassay for the quantitative determination of Anti-Infliximab antibodies in human serum and plasma.
Is it COVID-19? Is it Flu? Lab-comparable results in minutes. Verify potential infection quickly with a rapid microfluidic assay that provides actionable and lab-comparable results in 12 mins for patients suspected of Flu and/or COVID-19, to help decision making and guide treatment.
Is it RSV? Is it COVID-19? Actionable results in minutes. Verify potential infection and help guide infection control measures quickly with a rapid microfluidic assay that provides actionable results in 12 minutes, for patients suspected of RSV and/or COVID-19.
Closed, scalable electroporation system for GMP-compliant cell therapy manufacturing.
Accurately quantitate immunosuppressive drug levels in human whole blood samples with MassTrak Immunosuppressant Calibrator, Quality Control, and Internal Standard sets.
Our unique combination of custom antibody development, lateral flow development and manufacturing services, signal enhancement technology and our mobile diagnostic platform are shaping the future of lateral flow. Our partnership approach allows you to work with one company to reach your assay goals.
BBI Solutions’ Novarum™ technology transforms a smartphone into a mobile diagnostic platform, empowering users to read and share the results of rapid tests at the point of care.
